Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) EPS (Basic) (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed EPS (Basic) for 16 consecutive years, with $0.01 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 125.0% to $0.01 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.02, a 115.38% increase, with the full-year FY2024 number at -$0.12, down 1300.0% from a year prior.
  • EPS (Basic) was $0.01 for Q3 2025 at Xtant Medical Holdings, down from $0.03 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.07 in Q3 2023 to a low of -$0.04 in Q3 2024.
  • A 5-year average of -$0.01 and a median of -$0.02 in 2021 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): tumbled 8305.06% in 2022, then soared 333.33% in 2023.
  • Xtant Medical Holdings' EPS (Basic) stood at -$0.03 in 2021, then soared by 33.33% to -$0.02 in 2022, then crashed by 50.0% to -$0.03 in 2023, then skyrocketed by 33.33% to -$0.02 in 2024, then soared by 150.0% to $0.01 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's EPS (Basic) are $0.01 (Q3 2025), $0.03 (Q2 2025), and $0.0 (Q1 2025).